Wheeler Kurt
CIK 0001252525 Name as filed on the most recent filing
Filed as Wheeler Kurt (115)
191 transaction lines · from 115 filings · filed 2004-02-23 to 2018-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Entasis Therapeutics Holdings Inc. 1 filings
- ISSUER Forty Seven, Inc. 1 filings
- ISSUER Tetralogic Pharmaceuticals Corp 5 filings
- ISSUER Globus Medical Inc 3 filings
- ISSUER Oxford Immunotec Global PLC 6 filings
- ISSUER Aerie Pharmaceuticals Inc 6 filings
- ISSUER Ophthotech Corp. 1 filings
- ISSUER Somaxon Pharmaceuticals, Inc. 13 filings
- ISSUER Achillion Pharmaceuticals Inc 8 filings
- ISSUER Zalicus Inc. 10 filings
- ISSUER Zogenix, Inc. 2 filings
- ISSUER Avanir Pharmaceuticals, Inc. 5 filings
- ISSUER Pharmathene, Inc 3 filings
- ISSUER Senorx Inc 3 filings
- ISSUER Poniard Pharmaceuticals, Inc. 2 filings
- ISSUER EnteroMedics Inc 2 filings
- ISSUER ARYx Therapeutics, Inc. 2 filings
- ISSUER Metabasis Therapeutics Inc 3 filings
- ISSUER Pharmasset Inc 3 filings
- ISSUER Hemosense Inc 2 filings
- ISSUER Helicos Biosciences Corp 1 filings
- ISSUER Cryocor Inc 2 filings
- ISSUER Cotherix Inc 3 filings
- ISSUER Tercica Inc 4 filings
- ISSUER Critical Therapeutics Inc 4 filings
- ISSUER Barrier Therapeutics Inc 4 filings
- ISSUER Rigel Pharmaceuticals Inc 16 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
24 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2018-09-28 |
Entasis Therapeutics Holdings Inc. ETTX |
P, Open-market purchase | 453,395 acquired | 15.00 | 6,800,925.00 | Form 4, filing 0001209191-18-053534 | |
| 2018-07-02 |
Forty Seven, Inc. FTSV |
P, Open-market purchase | 200,000 acquired | 16.00 | 3,200,000.00 | Form 4, filing 0001209191-18-040426 | |
| 2016-02-09 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 230,507 disposed | 0.16 | 36,881.12 | Form 4, filing 0001012975-16-000991 | |
| 2016-02-08 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 103,123 disposed | 0.19 | 19,593.37 | Form 4, filing 0001012975-16-000991 | |
| 2016-02-05 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 832,881 disposed | 0.20 | 166,576.20 | Form 4, filing 0001012975-16-000980 | |
| 2016-02-04 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 500,026 disposed | 0.14 | 70,003.64 | Form 4, filing 0001012975-16-000980 | |
| 2016-02-03 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 82,583 disposed | 0.15 | 12,387.45 | Form 4, filing 0001012975-16-000980 | |
| 2016-02-02 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 176,306 disposed | 0.17 | 29,972.02 | Form 4, filing 0001012975-16-000957 | |
| 2016-02-01 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 140,000 disposed | 0.20 | 28,000.00 | Form 4, filing 0001012975-16-000957 | |
| 2016-01-29 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 52,826 disposed | 0.26 | 13,734.76 | Form 4, filing 0001012975-16-000957 | |
| 2016-01-28 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 32,521 disposed | 0.26 | 8,455.46 | Form 4, filing 0001012975-16-000938 | |
| 2016-01-27 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 209,984 disposed | 0.27 | 56,695.68 | Form 4, filing 0001012975-16-000938 | |
| 2016-01-26 |
Tetralogic Pharmaceuticals Corp TLOG |
S, Open-market sale | 69,425 disposed | 0.30 | 20,827.50 | Form 4, filing 0001012975-16-000938 | |
| 2016-01-06 |
Globus Medical Inc GMED |
S, Open-market sale | 15,045 disposed | 27.50 | 413,737.50 | Form 4, filing 0001209191-16-089890 | |
| 2016-01-04 |
Globus Medical Inc GMED |
S, Open-market sale | 255 disposed | 27.50 | 7,012.50 | Form 4, filing 0001209191-16-089890 | |
| 2015-06-16 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 39,701 disposed | 14.30 | 567,724.30 | Form 4, filing 0001012975-15-000491 | |
| 2015-06-15 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 1,529 disposed | 14.27 | 21,818.83 | Form 4, filing 0001012975-15-000491 | |
| 2015-06-12 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 6,430 disposed | 14.25 | 91,627.50 | Form 4, filing 0001012975-15-000485 | |
| 2015-06-11 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 25,168 disposed | 14.27 | 359,147.36 | Form 4, filing 0001012975-15-000485 | |
| 2015-06-10 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 8,987 disposed | 14.32 | 128,693.84 | Form 4, filing 0001012975-15-000479 | |
| 2015-06-09 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 13,000 disposed | 14.26 | 185,380.00 | Form 4, filing 0001012975-15-000479 | |
| 2015-06-08 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 2,662 disposed | 14.25 | 37,933.50 | Form 4, filing 0001012975-15-000479 | |
| 2015-06-03 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 10,450 disposed | 14.32 | 149,644.00 | Form 4, filing 0001012975-15-000473 | |
| 2015-06-02 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 11,014 disposed | 14.25 | 156,949.50 | Form 4, filing 0001012975-15-000473 | |
| 2015-06-01 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 15,010 disposed | 14.29 | 214,492.90 | Form 4, filing 0001012975-15-000473 | |
| 2015-03-23 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 26,300 disposed | 14.44 | 379,772.00 | Form 4, filing 0001012975-15-000242 | |
| 2015-03-20 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 27,115 disposed | 14.53 | 393,980.95 | Form 4, filing 0001012975-15-000242 | |
| 2015-03-19 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 50,012 disposed | 14.61 | 730,675.32 | Form 4, filing 0001012975-15-000238 | |
| 2015-03-18 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 25,000 disposed | 14.68 | 367,000.00 | Form 4, filing 0001012975-15-000238 | |
| 2015-03-17 |
Oxford Immunotec Global PLC OXFD |
S, Open-market sale | 79,307 disposed | 14.67 | 1,163,433.69 | Form 4, filing 0001012975-15-000238 | |
| 2015-01-08 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 175,000 disposed | 31.11 | 5,444,250.00 | Form 4, filing 0001012975-15-000017 | |
| 2015-01-05 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 13,420 disposed | 30.67 | 411,591.40 | Form 4, filing 0001012975-15-000003 | |
| 2015-01-05 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 10,200 disposed | 31.11 | 317,322.00 | Form 4, filing 0001012975-15-000003 | |
| 2014-12-29 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 6,214 disposed | 30.03 | 186,606.42 | Form 4, filing 0001012975-14-000835 | |
| 2014-12-26 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 74,510 disposed | 30.05 | 2,239,025.50 | Form 4, filing 0001012975-14-000835 | |
| 2014-12-23 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 263 disposed | 30.00 | 7,890.00 | Form 4, filing 0001012975-14-000826 | |
| 2014-12-22 |
Aerie Pharmaceuticals Inc AERI |
S, Open-market sale | 49,441 disposed | 30.36 | 1,501,028.76 | Form 4, filing 0001012975-14-000826 | |
| 2014-06-11 |
Ophthotech Corp. OPHT |
S, Open-market sale | 29,217 disposed | 44.53 | 1,301,073.91 | Form 4, filing 0001012975-14-000396 | |
| 2014-06-11 |
Ophthotech Corp. OPHT |
S, Open-market sale | 500 disposed | 44.32 | 22,160.00 | Form 4, filing 0001012975-14-000396 | |
| 2014-06-10 |
Ophthotech Corp. OPHT |
S, Open-market sale | 79,824 disposed | 44.66 | 3,564,987.73 | Form 4, filing 0001012975-14-000396 | |
| 2014-06-10 |
Ophthotech Corp. OPHT |
S, Open-market sale | 36,880 disposed | 45.90 | 1,692,629.73 | Form 4, filing 0001012975-14-000396 | |
| 2014-06-10 |
Ophthotech Corp. OPHT |
S, Open-market sale | 200 disposed | 46.80 | 9,360.00 | Form 4, filing 0001012975-14-000396 | |
| 2014-06-09 |
Ophthotech Corp. OPHT |
S, Open-market sale | 39,362 disposed | 46.78 | 1,841,500.00 | Form 4, filing 0001012975-14-000396 | |
| 2014-06-09 |
Ophthotech Corp. OPHT |
S, Open-market sale | 25,697 disposed | 46.02 | 1,182,462.87 | Form 4, filing 0001012975-14-000396 | |
| 2013-12-17 |
Tetralogic Pharmaceuticals Corp TLOG |
P, Open-market purchase | 1,425,063 acquired | 7.00 | 9,975,441.00 | Form 4, filing 0001192482-13-000240 | |
| 2013-10-25 |
Aerie Pharmaceuticals Inc AERI |
P, Open-market purchase | 321,000 acquired | 10.00 | 3,210,000.00 | Form 4, filing 0001012975-15-000076 | |
| 2013-10-25 |
Aerie Pharmaceuticals Inc AERI |
P, Open-market purchase | 321,000 acquired | 10.00 | 3,210,000.00 | Form 4, filing 0001012975-13-000497 | |
| 2012-08-08 |
Globus Medical Inc GMED |
S, Open-market sale | 804,232 disposed | 11.16 | 8,975,229.12 | Form 4, filing 0001209191-12-041319 | |
| 2012-08-08 |
Globus Medical Inc GMED |
S, Open-market sale | 804,232 disposed | 11.16 | 8,975,229.12 | Form 4, filing 0001209191-12-041325 | |
| 2012-07-09 |
Somaxon Pharmaceuticals, Inc. SOMX |
S, Open-market sale | 1,624,574 disposed | 0.31 | 498,744.22 | Form 4, filing 0001209191-12-037738 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 7
- Open-market sale 17
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. WHEELER KURT, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001252525
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6